Zydus to make Biotax 1g injection available with 10ml sterile water post Nepal regulator's objection
By Rediff Money Desk, New Delhi Jun 19, 2024 16:03
Zydus Life Sciences will now provide 10ml sterile water with its Biotax 1g injection in Nepal after the country's drug regulator objected to the earlier 5ml supply. The company clarified that the change is purely for convenience and does not affect the product's quality or patient safety.
New Delhi, Jun 19 (PTI) Zydus group on Wednesday said it will make its antibiotic injection Biotax 1g with 10ml sterile water available in Nepal after the Department of Drug Administration of that country raised objection for not providing the solvent.
The Indian pharmaceuticals group refuted a media report that the Department of Drug Administration, Nepal has suspended sales and distribution of Biotax 1gm due to "serious health risks" stating these were "misleading and erroneous" as it complies with all quality parameters as per approved specification.
"The letter received from the Department of Drug Administration, Nepal, refers to the quantity of sterile water for injection made available with the product," Zydus Group said in a statement.
Zydus has supplied 5ml sterile water for injection along with the product but the direction for use states "use 3ml for intramuscular injection and 10ml for intravenous injection".
"The objection raised by the agency is only with reference to the non-supply of 10ml sterile water for injection along with the product," the statement said, adding that this does not have any impact on product quality nor does it pose any risk to patient safety as stated in the article.
For intramuscular injection, the product can be constituted with 3ml sterile water provided with the product. For intravenous injection, the product should be reconstituted by using 10ml sterile water for injection separately, it added.
Further, it said, "Based on the letter received from DDA Nepal, we are amending as per the agency's requirement, the product will be made available with 10ml sterile water for injection instead of 5ml so that the product can be administered for intramuscular as well as intravenous as per the patient's requirement."
Zydus group asserted that "no product complaint or any adverse event because of the usage of the product has been received from Nepal since the product commercialisation in 2018. The product Biotax 1g injection has been renewed every year as per DDA, Nepal regulation.
The Indian pharmaceuticals group refuted a media report that the Department of Drug Administration, Nepal has suspended sales and distribution of Biotax 1gm due to "serious health risks" stating these were "misleading and erroneous" as it complies with all quality parameters as per approved specification.
"The letter received from the Department of Drug Administration, Nepal, refers to the quantity of sterile water for injection made available with the product," Zydus Group said in a statement.
Zydus has supplied 5ml sterile water for injection along with the product but the direction for use states "use 3ml for intramuscular injection and 10ml for intravenous injection".
"The objection raised by the agency is only with reference to the non-supply of 10ml sterile water for injection along with the product," the statement said, adding that this does not have any impact on product quality nor does it pose any risk to patient safety as stated in the article.
For intramuscular injection, the product can be constituted with 3ml sterile water provided with the product. For intravenous injection, the product should be reconstituted by using 10ml sterile water for injection separately, it added.
Further, it said, "Based on the letter received from DDA Nepal, we are amending as per the agency's requirement, the product will be made available with 10ml sterile water for injection instead of 5ml so that the product can be administered for intramuscular as well as intravenous as per the patient's requirement."
Zydus group asserted that "no product complaint or any adverse event because of the usage of the product has been received from Nepal since the product commercialisation in 2018. The product Biotax 1g injection has been renewed every year as per DDA, Nepal regulation.
Source: PTI
Read More On:
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- ARC Finance
- 1.51 (+ 2.72)
- 99106131
- Vodafone Idea L
- 8.27 (+ 1.72)
- 37910491
- Guj. Toolroom Lt
- 18.98 (+ 4.98)
- 33052379
- Srestha Finvest
- 0.81 ( -2.41)
- 24087791
- Filatex Fashions
- 0.69 ( -4.17)
- 20455844
MORE NEWS
Adani Wilmar to Emulate ITC, Expand FMCG Portfolio
Adani Wilmar, India's largest edible oil company, plans to leverage its core business...
India to Boost Exports: 20 Nations Meet Jan 6-8
Indian officials from 20 countries will meet in New Delhi to discuss strategies to...
Karur Vysya Bank Expands in Tamil Nadu with Two...
Karur Vysya Bank has opened two new branches in Tamil Nadu, bringing its total branch...